BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 34063947)

  • 1. Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation.
    Kasatkina LA; Rittchen S; Sturm EM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation.
    Kasatkina LA; Heinemann A; Hudz YA; Thomas D; Sturm EM
    Biochem Pharmacol; 2020 Apr; 174():113783. PubMed ID: 31881191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of control of neuron survival by the endocannabinoid system.
    Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
    Curr Pharm Des; 2008; 14(23):2279-88. PubMed ID: 18781978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid and vanilloid pathways mediate opposing forms of synaptic plasticity in corticotropin-releasing hormone neurons.
    Jamieson BB; Kim JS; Iremonger KJ
    J Neuroendocrinol; 2022 Apr; 34(4):e13084. PubMed ID: 35034400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Dependent and Independent Regulation of Voltage-Gated Ca
    Boczek T; Zylinska L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
    Bari M; Rapino C; Mozetic P; Maccarrone M
    Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of synaptic function by endocannabinoid-mediated retrograde signaling.
    Kano M
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(7):235-50. PubMed ID: 25169670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
    Bisogno T; Di Marzo V
    CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid signaling and synaptic function.
    Castillo PE; Younts TJ; Chávez AE; Hashimotodani Y
    Neuron; 2012 Oct; 76(1):70-81. PubMed ID: 23040807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endocannabinoids in pain modulation.
    Zogopoulos P; Vasileiou I; Patsouris E; Theocharis SE
    Fundam Clin Pharmacol; 2013 Feb; 27(1):64-80. PubMed ID: 23278562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.
    Rapino C; Tortolani D; Scipioni L; Maccarrone M
    Curr Neuropharmacol; 2018; 16(7):959-970. PubMed ID: 28738764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
    Hwang J; Adamson C; Butler D; Janero DR; Makriyannis A; Bahr BA
    Life Sci; 2010 Apr; 86(15-16):615-23. PubMed ID: 19527737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.
    Kirilly E; Hunyady L; Bagdy G
    J Neural Transm (Vienna); 2013 Jan; 120(1):177-86. PubMed ID: 22990678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?
    Melis M; Pistis M
    Curr Neuropharmacol; 2007 Dec; 5(4):268-77. PubMed ID: 19305743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids in the gastrointestinal tract.
    Lee Y; Jo J; Chung HY; Pothoulakis C; Im E
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G655-G666. PubMed ID: 27538961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
    J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.